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Abstract
Epigenetic regulation, including DNA methylation, plays an important role in several differentiation processes and possibly
in adipocyte differentiation. To search for genes that show methylation change during adipogenesis, genome-wide DNA
methylation analysis in insulin-induced adipogenesis of 3T3-L1 preadipocyte cells was performed using a method called
microarray-based integrated analysis of methylation by isoschizomers (MIAMI). The MIAMI revealed that Hpa II sites of exon
1 in a Rho guanine nucleotide exchange factor 19 (ARHGEF19; WGEF) gene were demethylated during adipocyte
differentiation of 3T3-L1 cells. Deletion of the region containing cytosine-guanine (CpG) sites that showed methylation
change suppressed transcriptional activity in the reporter assay, indicating that this region regulates WGEF transcription.
WGEF expression in 3T3-L1 cells was reduced during adipocyte differentiation, and high-fat diet-induced obese mice also
showed lower expression of WGEF gene than control mice in white adipose tissue. Additionally, forced expression of WGEF
in 3T3-L1 cells down-regulated the expression of adipogenic marker genes and inhibited the adipogenic program. This
study clarified that adipogenesis was regulated by WGEF expression through DNA methylation change.
Citation: Horii T, Morita S, Kimura M, Hatada I (2009) Epigenetic Regulation of Adipocyte Differentiation by a Rho Guanine Nucleotide Exchange Factor,
WGEF. PLoS ONE 4(6): e5809. doi:10.1371/journal.pone.0005809
Editor: Jo ¨rg Hoheisel, Deutsches Krebsforschungszentrum, Germany
Received November 17, 2008; Accepted May 4, 2009; Published June 5, 2009
Copyright:  2009 Horii et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by grants from the Japanese Science and Technology Agency, the Ministry of Education, Culture, Sports, Science and
Technology of Japan, and the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ihatada@showa.gunma-u.ac.jp
Introduction
5-methylcytosine is the only covalent DNA modification known
in vertebrates [1]. This epigenetic modification regulates gene
expression and is essential for differentiation, embryonic develop-
ment [2], genomic imprinting [3], and X-chromosome inactiva-
tion [4]. Recently, it was reported that methylation change of six
CpG sites in a retrotransposon upstream of the transcription start
site of the Agouti gene was responsible for obesity in A
vy/a mutant
mice [5,6]. Accumulation of adipocytes usually results in obesity,
and genes that regulate adipogenesis could be regulated by
epigenetic DNA modifications; thus, it is very important to search
for adipogenic genes that are regulatd by DNA methylation.
Previously, we developed a genome-wide DNA methylation
analysis called MIAMI using a microarray [7]. With this method,
we detected DNA methylation using the methylation-sensitive
restrictionenzymeHpa II and itsmethylation-insensitive isoschizomer
Msp I. Hpa II cleavage differences are usually related to methylation
differences of two samples. This method has already been utilized for
genome-wide profiling of lung cancer [7] and neural differentiation
[8]. In this study, the MIAMI method was applied to genome-wide
DNA methylation analysis for insulin-induced adipogenesis of 3T3-
L1 preadipocyte cells, and we found a dramatic methylation change
of Rho guanine nucleotide exchange factor 19 (ARHGEF19; WGEF)
[9] during adipocyte differentiation.
WGEF is one of the members of Rho guanine nucleotide
exchange factors (RhoGEFs). RhoGEFs stimulate the exchange of
GDP for GTP to generate the activated form of GTPases, which is
then capable of recognizing downstream targets, or effector
proteins [10]. The Rho family of small GTPases, activated by
RhoGEFs, has been shown to regulate a variety of cytoskeletal-
dependent cell functions, such as cell morphology changes,
formation of focal adhesions and stress fibers, platelet aggregation,
cytokinesis, cell-cycle progression, and neurite outgrowth and
guidance [11]. In addition, Rho family proteins are also involved
in the differentiation of many cell types, including neurons, T
lymphocytes, myocytes and keratinocytes [12–15]. Thus, Rho-
GEFs have important roles in many physiological and pathophys-
iological mechanisms via the activation of Rho GTPases. On the
other hand, WGEF is expressed mainly in the intestine, liver,
heart, and kidney, and it can mainly activate RhoA [9]. According
to another research, RhoA inhibits adipogenesis by the regulation
of cytoskeletal tension through the RhoA-Rho kinase (ROCK)
signaling pathway [16]. These two reports are associated with the
existence of adipogenic regulation through the WGEF-RhoA-
ROCK signaling pathway; however, no direct evidences have
been demonstrated.
Here, we show that epigenetic regulation, including DNA
methylation in the WGEF gene, plays an important role in
transcriptional activity, and we also prove that WGEF regulates




3T3-L1 cells were grown and maintained in DMEM containing
10% fetal bovine serum (Gibco). For adipocyte differentiation,
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described above supplemented with 1.7 M insulin (Sigma),
0.5 mM dexamethasone (Sigma), and 0.8 mM isobutylmethyl
xanthine (IBMX, Sigma) for 2 days. After 2 days (day3), this
medium was replaced by medium supplemented with 1.7 M
insulin only. Y-27632 (Wako Pure Chemical Industries) known as
a ROCK inhibitor, was supplemented with differentiation culture
medium as necessary.
Mice
C57BL/6J mice were purchased from Charles River Japan. Six-
week-old mice were housed in box cages, maintained on a 12-h
light/12-h dark cycle and fed for 15 weeks either a normal diet
(CE-2, CLEA Japan) or a high-fat diet (HFD32, CLEA Japan). All
animal experiments were conducted according to the guidelines of
the Animal Care and Experimentation Committee, Gunma
University, Showa Campus, Japan.
Methylation profiling by MIAMI
Transcriptional start sites for the genes were characterized on the
basis of the National Center for Biotechnology Information (NCBI)
annotation and/or Database of Transcriptional Start Sites
(DBTSS). A DNA sequence around a transcriptional start site was
extracted for each gene and subjected to megaBlast to select regions
whose scores relative to the mouse genome were less than 30.0. In
these regions all possible 60-mer probes in Hpa II fragments were
selectedfrom 400base pairsupstreamto200basepairsdownstream
of the transcriptional start site for each gene on condition that they
had a self-complementarity score of less than 8.0 by Primer3. These
probes were subjected to megaBlast and the probe nearest to the
transcriptional start site, which had a score relative to the mouse
genome of less than 40.0, was selected. Finally, 10,263 probes were
selected. Microarrays were made using an ink-jet oligonucleotide
synthesizer as described [17]. The MIAMI method was performed
using 1 mg of genomic DNA as previously described [7]. The
complete experimental procedure is available at http://grc.dept.
med.gunma-u.ac.jp/,gene/image/MIAMI%20Protocol%20V4.pdf.
To judge changes in methylation, we used the difference in
methylation-sensitive Hpa II cleavage and methylation-insensitive
Msp I cleavage between samples.
Combined bisulfite restriction analysis (COBRA) and
bisulfite sequencing
Bisulfite treatment of genomic DNA was performed using a
CpGenome DNA modification kit (INTERGEN). COBRA was
performed as described [18]. PCR primers and restriction
enzymes are shown in Table 1. DNA fragments were separated
on 8% polyacrylamide gel. PCR products were also subcloned into
the TA cloning vector (pCR 2.1; Invitrogen). Ten positive clones
in each sample were sequenced using the Big Dye terminator
method (ABI PRISM 3100).
Quantitative real-time RT-PCR
Cells were collected and total RNA was extracted with
TRIZOL (Invitrogen) according to the manufacturer’s instruc-
tions, and RNA was treated with DNaseI at 37uC for 15 min to
remove genomic DNA contamination. Total RNA was reverse
transcribed using Superscript II (TaKaRa) and Oligo(dT)12–18
primer (TaKaRa) in a total volume of 20 mL. Quantitative real-
time PCR was performed using SYBR Premix Ex Taq (Perfect
Real Time, TaKaRa). The PCR cocktail was heated initially at
95uC for 10 sec to activate it. Subsequent PCR reaction was
carried out at 95uC for 5 sec and at 60uC for 30 sec for 40 cycles
in an ABI 7700 sequence detector. In each run, the dilution series
of cDNA from 3T3-L1 cells were amplified to serve as a standard
curve for the calculation of relative quantities of the target gene
using Sequence Detector Software v1.7 (comparative CT method).
All results were obtained from at least two independent
Table 1. The primer sequence used for COBRA and real-time PCR.
Site or gene name Primer sequence Restriction enzyme
COBRA
E-box-like 59-TTTTTTTGTATTTGATTGGTTAAAT-39 HpyCH4 IV
59-ATTACTAACCCAAAACCCTACCTC-39
HpaII site1 59-TTTTTTTGTATTTGATTGGTTAAAT-39 Hpy188 I
59-ACCATATCAACATAACTCCAAATCC-39
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the experiments are shown in Table 1. The mRNA levels of all
genes were normalized using b-actin as an internal control.
Luciferase Reporter Assays
The upstream region of the WGEF gene containing exon 1
(2500 to +167) was amplified by PCR from the genomic DNA of
3T3-L1 cells, and the fragment was cloned into pGL3-Basic vector
(Promega). Reporter constructs with 10 nucleotides deletions
around the –81 (E-box-like site), 240 and +120 (Hpa II site2)
positions were also produced by restriction enzyme and modified
PCR primer sets. 3T3-L1 cells were grown in 24-well plates and
720 ng of the luciferase reporter construct per well was transfected
using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s directions. To normalize the luciferase activity, 80 ng of a
control plasmid having a Renilla luciferase sequence was co-
transfected into the cells. Cells were harvested 48 h post-
transfection for 3T3-L1 cells in reporter lysis buffer (Promega).
Luciferase expression was detected with a luciferase assay system
(Promega).
Plasmids and transfections
The pIRES2-EGFP mammalian expression vector (Clontech)
containing the mouse WGEF cDNA sequence was generated using
PCR with primers specific for ORF of the WGEF cDNA. Cells were
transfected with Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s directions.As a control, the expression vector without
WGEF cDNA was also transfected. Pools of cells were stably selected
with G418 (800 mg/mL) prior to experimental analysis.
Oil red O staining
Oil Red O (ORO) staining for lipids was performed on 3T3-L1
cells that were fixed with 10% formalin in PBS for 10 min and
washed in PBS. The cells were then incubated with 90 mg/mL Oil
Red O (Sigma) solution dissolved in 60% 2-propanol for 20 min at
room temperature.
Statistical analysis
Data analyses were performed using Statcel2 for Macintosh OS
X. All data are presented as the mean +/2 standard deviations.
Statistical analyses of the luciferase reporter assay and real-time
Figure 1. Application of the MIAMI method to 3T3-L1 cells. We applied the MIAMI method to 3T3-L1 cells that were differentiated (DIF) and
undifferentiated (UNDIF). We defined resistance as reciprocal sensitivity. Therefore, Hpa II-sensitive (cleavable) DNA and Msp I-sensitive (cleavable)
DNA were amplified and used to calculate Hpa II resistance (HR) and Msp I resistance (MR), respectively. Values of log (HRDIF/HRUNDIF) are plotted on
the x-axis and log (MRDIF/MRUNDIF) are plotted on the y-axis. Two genes indicated by arrows are clearly hypomethylated after differentiation.
doi:10.1371/journal.pone.0005809.g001
WGEF Regulates Adipogenesis
PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5809Figure 2. DNA methylation change of WGEF gene during adipogenesis. A. CpG sites located on exon 1 and upstream region of WGEF gene.
Circles and numbers indicate positions of CpGs relative to transcription start site (+1). B. DNA methylation profiles of individual CpG sites at WGEF
upstream region in undifferentiated and differentiated (day 4 of differentiation culture) 3T3-L1 cells by sodium bisulfite sequencing. Each PCR
product was subcloned, and 10 clones were subjected to nucleotide sequencing analysis. The status, either unmethylated (open circle) or methylated
(closed circle), is indicated at each CpG site. Methylation percentages of undifferentiated cells (open bar) and differentiated cells (closed bar) at each
CpG site are summarized on the right. *CpG sites that were demethylated after differentiation. C. COBRA analysis of indicated CpG sites. PCR
products with methylated CpG are digested by restriction enzymes.
doi:10.1371/journal.pone.0005809.g002
WGEF Regulates Adipogenesis
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Student’s t-test, respectively. Differences were considered signifi-
cant when P,0.05.
Results
DNA methylation changes during the adipocyte
differentiation of 3T3-L1 cells
Changes in methylation during adipocyte differentiation were
analyzed by comparing undifferentiated and differentiated 3T3-L1
cells using the MIAMI method. The probes are located on Hpa II
fragments of less than 600 base pairs and cover 10,263 genes. Hpa
II cleavage differences are related to methylation differences of two
samples before and after differentiation. We found that
6430573B13Rik (WGEF) and 4931406C07Rik genes clearly
showed demethylation after differentiation (Fig. 1). As a result of
RT-PCR, significant changes of mRNA expression during
differentiation were observed in WGEF gene but not in
4931406C07Rik gene (data not shown). RhoGEF families,
including WGEF, have important roles in many physiological
and pathophysiological mechanisms via the activation of Rho
GTPases; therefore, we performed more detailed analyses of the
WGEF gene. Two Hpa II sites located on both sites of the probe
are located in exon 1 of the WGEF gene (Fig. 2A). We also
performed bisulfite sequencing and COBRA for the WGEF gene
and found that the methylation status showed good agreement
with that of MIAMI results. In particular, Hpa II site2 (120 bp
downstream of exon 1 start site; +120) was almost completely
methylated before differentiation, whereas strong demethylation
was shown after days 5 of differentiation culture prior to full
differentiation (Fig. 2B, C). Moreover, 59-CACGTT-39 E-box-like
site [19], Hpa II site1 and 240 position also showed slight
demethylation. In contrast, clear methylation changes were not
seen in CREB [20] and at 269 and 294 positions.
Expression changes during adipocyte differentiation of
3T3-L1 cells
Expression changes during adipogenesis were analyzed by
quantitative real-time RT-PCR. We observed over 50% reduction
in WGEF mRNA at day 5 of differentiation culture when lipid
droplets appeared and the methylation change was completed,
and finally the relative expression level decreased to approximately
10% (Fig. 3A, B). In contrast, adipogenic markers, PPAR-c [21],
Adipsin [22] and Gapdh [23] were upregulated during adipogen-
esis. We also investigated the expression pattern of the WGEF
gene in various mouse tissues. High expression was seen in the
brain, heart and liver, and also at a lower level in the kidney and
intestine (Fig. 3C). On the other hand, less expression was seen in
the skeletal muscle, spleen, fat and testes. Overall, this result is
identical to the result of Northern blot analysis, as reported [9].
Interestingly, lower expression of WGEF mRNA was observed in
white adipose tissue of high-fat diet-induced obese mice (Fig. 3D)
Figure 4. Transcriptional activity regulated by WGEF upstream region. WGEF upstream region containing exon 1 was ligated to pGL3-Basic
vector. Reporter constructs with 10 nucleotides deletions (281, 240 and +120 positions) were produced. These reporter constructs were transfected
to 3T3-L1 cells. Transcriptional activity is shown as relative luciferase (Luc) activity. Data are the mean +/2 standard deviations in triplicate of three
independent experiments: *P,0.05.
doi:10.1371/journal.pone.0005809.g004
Figure 3. Reduction of WGEF mRNA expression during adipogenesis. A. Representative cell morphology of 3T3-L1 cells at days 1, 3, 5 and 9
of differentiation culture. Lipid droplets appeared by days 5 of culture. B. Quantitative real-time RT-PCR was performed for WGEF, PPAR-c, Adipsin
and Gapdh. Relative expression of each gene was estimated at days 1, 3, 5, 7 and 9 of differentiation culture. The b-actin gene was used to
standardize the data. Data represent the mean +/2 standard deviations in triplicate. C. WGEF mRNA distribution in mouse tissues. Quantitative real-
time RT-PCR was performed for the brain (B), heart (H), kidney (K), lung (Lu), skeletal muscle (SM), intestine (I), spleen (Sp), thymus (Th), stomach (St),
fat (F) and testis (Te). The b-actin gene was used to standardize the data. Data are the mean +/2 standard deviations in triplicate. D. WGEF mRNA
expression in white adipose tissue of control mice or high-fat diet (HFD)-induced obese mice (n=6, respectively). The b-actin gene was used to
standardize the data. Data are the mean +/2 standard deviations in triplicate: *P,0.05
doi:10.1371/journal.pone.0005809.g003
WGEF Regulates Adipogenesis
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suggest that WGEF gene is related to inhibition of adipocyte
differentiation both in vitro and in vivo.
Regulation of transcriptional activity
The highest expression of WGEF mRNA was observed in
undifferentiated 3T3-L1 cells, and this expression decreased
during differentiation. These findings indicate the possibility that
methylation change in exon 1 and the upstream region regulates
transcriptional activity of the WGEF gene; therefore, luciferase
reporter vectors with 10 nucleotides deletions around the 281 (E-
box-like site), 240 and +120 (Hpa II site2) positions of these
regions were examined for transcriptional activity (Fig. 4).
Interestingly, deletions of these areas downregulated luciferase
activity except for the 240 position, indicating that both 281 and
+120 positions regulate mRNA expression of the WGEF gene.
Inhibition of adipogenesis of 3T3-L1 cells by WGEF
Our data demonstrate strong down-regulation of WGEF
expression during 3T3-L1 adipogenesis, suggesting that this gene
may be essential for maintaining the undifferentiated state of these
cells. In order to determine if WGEF can regulate the process of
adipogenesis, we made six WGEF-transfected stable cell lines
(W1–W6) and five vector control (GFP-transfected) stable cell lines
(G1–G5) (Fig. 5A, B). These WGEF-transfected cell lines
expressed WGEF even after 9 days of treatment for differentiation
(Fig. 5B). As a visual measure of the effect of WGEF on
adipogenesis, we carried out Oil Red O (ORO) staining to detect
lipid granules in 3T3-L1 cells. Fully differentiated 3T3-L1 cells
produce lipid granules that can be stained with ORO. We found
that vector control cells exhibited clearly more stained lipid
droplets than WGEF-transfected cells (Fig. 5C). According to real-
time RT-PCR analysis, excessive expression of WGEF inhibited
adipogenesis, whereas over 50% reduction in WGEF expression
could not inhibit (i.e. W5 cell line). Further, in the same stable cell
line, cells with a high expression of WGEF were not differentiated,
whereas those with a low expression produced lipid granules
(Fig. 5D). Additionally, real-time RT-PCR analysis of the
adipogenic markers PPAR-c, Adipsin, and Gapdh demonstrated
strong inhibition of gene expressions in WGEF-transfected cells
compared to vector-transfected cells (Fig. 6A), demonstrating that
WGEF is capable of inhibiting the adipogenic program. Generally,
activated RhoA effect downstream target, ROCK which inhibits
adipogenesis by control of cytoskeletal tension [16]. If overexpres-
sion of WGEF inhibited adipogenesis through the RhoA-ROCK
signaling pathway, adipogenesis could be induced by inhibition of
ROCK in WGEF-transfected cells. We treated WGEF transfected
cells with Y-27632 which was known as a ROCK inhibitor, and
we found that adipogenesis was induced in a dose-dependent
manner with concentration of 0 mM, 10 mM and 30 mM. This
indicates that the WGEF-RhoA-ROCK signaling pathway could
inhibit adipogenesis in 3T3-L1 cells.
Discussion
Epigenetic regulation, including DNA methylation, plays an
important role in several differentiation processes. We profiled
global DNA methylation during adipocyte differentiation of 3T3-
L1 cells using a microarray-based method called MIAMI, and
found dramatic methylation change in the WGEF gene. Detailed
analyses clarified that methylation changes of WGEF were
completed prior to complete repression of the expression during
adipocyte differentiation. This finding indicates the possibility that
methylation change in exon 1 and the upstream region regulates
transcriptional activity of the WGEF gene. The results of luciferase
reporter assays show evidence that the region containing 281 (E-
box-like site) and +120 (Hpa II site2) positions regulates WGEF
transcription.
Generally, chromatin modification by CpG methylation has
been linked with transcriptional repression [25]. In contrast,
transcription of WGEF has been upregulated by CpG methyla-
tion. At first glance, the relationship between methylation and
transcription in WGEF seems to be contradictory; however, there
are some reports that methylation in the 59 or 39 region activates
gene expression. In human osteoblast-like MG63 cells, for
example, methylation in the distal promoter part of the PDPN
gene promotes PDPN transcription efficiently [26]. They hypoth-
esized that methylation-dependent protein-DNA interactions
stimulate transcription. The zinc finger protein Kaiso has also
been found to bind specifically to methylated sites in a sequence-
specific manner, activating functions [27]. Thus, the existence of
methylation-dependent proteins that promote transcription was
reported by some researchers. In the case of WGEF, methylation-
dependent binding proteins able to promote transcription may
bind to the upstream region of the WGEF gene. In fact, deletion of
the region containing E-box-like site and Hpa II site2 suppressed
transcriptional activity in the reporter assay, indicating that this
region regulates WGEF transcription at least.
In expression analysis, our data demonstrate a strong down-
regulation of WGEF expression during 3T3-L1 adipogenesis,
suggesting that this gene may be essential for maintaining the
undifferentiated status of these cells. High-fat diet-induced obese
mice showed lower expression of WGEF than control mice in
white adipose tissue, supporting this idea. According to expecta-
tions, an excessive or equivalent level forced the expression of
WGEF compared to undifferentiated cells that inhibited adipocyte
differentiation; however, more than 50% reduction of expression
level led to differentiation. Additionally, using real-time RT-PCR
analysis measuring adipogenic markers PPAR-c, Adipsin and
Gapdh, we observed a strong inhibition of marker gene expression
in WGEF-transfected cells compared to vector control transfected
cells. Thus, we have obtained the first evidence that WGEF
signaling pathways act as potential regulators of adipogenesis.
WGEF can activate Rho family G-proteins such as RhoA, Rac1
and Cdc42 [9]. Another study shows that RhoA inhibits
adipogenesis by activation of the RhoA effector, ROCK which
Figure 5. WGEF inhibits adipogenesis in 3T3-L1 cells. A. Expression vectors with/without WGEF cDNA were individually transfected into 3T3-
L1 cells, which were subsequently selected in G418-containing medium. Then, GFP-positive clones were analyzed. B. Quantitative real-time RT-PCR
was performed for total (endogenous and transgenic) WGEF. Relative expression of each cell line was estimated at day 9 of differentiation culture. The
b-actin gene was used to standardize the data. Data are the mean +/2 standard deviations in triplicate. C. Oil Red O staining of WGEF- and vector-
transfected 3T3-L1 cells subjected to 9 days of differentiation. Vector control cells exhibited significantly more stained lipid droplets than WGEF-
transfected cells, except for the W8 cell line which showed less than 50% WGEF expression compared to undifferentiated No TG cells. D. Cells with
high expression of WGEF (GFP) were not differentiated, whereas those with a low expression of WGEF (GFP) differentiated and produced lipid
granules (arrows) even in the same cell line.
doi:10.1371/journal.pone.0005809.g005
WGEF Regulates Adipogenesis
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two studies indirectly suggest the inhibition of adipogenesis by
WGEF-RhoA-ROCK signaling. In our study, WGEF-transfected
cells did not start adipogenesis, whereas they started adipogenesis
after treatment with RhoA-ROCK inhibitor, Y-27632. This result
directly shows that the inhibition of adipogenesis is caused by
Figure 6. WGEF inhibits adipogenesis through the RhoA-ROCK signaling pathway. A. 3T3-L1 cells were stably transfected with WGEF or
control vector (GFP). Quantitative real-time RT-PCR was performed for adipogenic markers PPAR-c, Adipsin and Gapdh. Relative mRNA expression
levels before (open bars) and after (closed bars) differentiation treatment are shown. Data are the means +/2 standard deviations (n=5, respectively):
*P,0.005 and **P,0.0005. B. WGEF-transfected cells (W3 and W6) were treated with the ROCK inhibitor, Y-27632. Oil Red O staining (Top) and
quantitative real-time RT-PCR for PPAR-c (bottom) show that adipogenesis was induced after treatment with Y-27632 in a dose-dependent manner.
Data are the means +/2 standard deviations.
doi:10.1371/journal.pone.0005809.g006
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including WGEF, activate Rho GTPases. In contrast, RhoGAPs
stimulate GTP hydrolysis, which results in the inactivation of Rho
GTPases. Interestingly, mice lacking p190-B RhoGAP show a
dramatic reduction of mature adipocytes because excessive Rho
activity in the absence of RhoGAPs inhibits adipogenesis [28]. In
other words, their report suggests that excessive RhoGEF
expression inhibits adipogenesis. Furthermore, it has been
reported that another member of RhoGEFs, GEFT, also inhibits
adipogenesis in 3T3-L1 cells via the activation of RhoA [29].
According to their report, cotransfection of GEFT with the PPAR-
c luciferase construct resulted in a reduction from baseline
luciferase activity. Our results also indicated the strong inhibition
of PPAR-c transcription by the forced expression of WGEF
(Fig. 6A). WGEF transfected cells that were treated with the
ROCK inhibitor, Y-27632 certainly started adipogenesis; howev-
er, the differentiation level of these cells did not reach that of
normal control cells (Fig. 6B). This suggests that WGEF blocks the
adipogenic program via not only the RhoA-ROCK signaling
pathway but also via other pathways, such as the PPAR-c-
mediated signaling pathway which is one of the most critical
programs of adipogenesis. In any case, it is clear that WGEF plays
a very important role in adipogenesis through the WGEF-RhoA-
ROCK signaling pathway by epigenetic regulation.
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